FT819
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for FT819, covering 2026-03-09 to 2026-03-19. Get the full timeline:
Most recent: Clinical Trial Update: FT819 in Subjects With B-cell Malignancies [Phase 1]